COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center Analysis

COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center Analysis

Lung transplant (LTx) recipients are at high risk for COVID-19 related morbidity and mortality. Data regarding pre-exposure prophylaxis (PrEP) with tixagevimab-cilgavimab in this population are scarce. We therefore evaluated COVID-19 breakthrough infections and COVID-19 related complications after P...

Full description

Bibliographic Details
Main Authors: Saartje Demolder, Veronique Schaevers, Katrien Lagrou, Paul De Munter, Hanne Beeckmans, Geert M. Verleden, Laurent Godinas, Lieven J. Dupont, Pascal Van Bleyenbergh, Natalie Lorent, Robin Vos
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Transplant International
Subjects:
COVID-19
lung transplantation
pre-exposure prophylaxis
tixagevimab-cilgavimab
outcome predictors
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2024.12061/full

Internet

https://www.frontierspartnerships.org/articles/10.3389/ti.2024.12061/full

Similar Items